MERCK & CO, INC. for MERCK & CO INC
A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 1st Quarter - Report (this page) | Apr 19, 2010 | $3,220,000 | Replaced |
| 1st Quarter - Amendment | May 17, 2011 | $3,220,000 | Yes |
What was lobbied
7 issue areas, each in the filer's own words, with who lobbied on it and where.
Medical/Disease Research/Clinical Labs MED
Approval and regulation of biosimilars (H.R. 1427; H.R. 1548; S. 726; H.R. 3200; S. 1679; H.R. 4872)
| Lobbyist | Covered position, as disclosed |
|---|---|
| ERIN DARLING | — |
| ELI JOSEPH | Leg. Ass't. White House Off. of Leg. Affairs |
| LAURIE MICHEL | — |
Financial Institutions/Investments/Securities FIN
End use of derivatives (no specific bill)
| Lobbyist | Covered position, as disclosed |
|---|---|
| JASON BENJAMIN VAN PELT | — |
Taxation/Internal Revenue Code TAX
Deferral of taxation of foreign earned income and corporate taxation (no specific legislation). Renewal and expansion of the R&D tax credit (Support H.R. 422; S. 1203)
| Lobbyist | Covered position, as disclosed |
|---|---|
| JASON BENJAMIN VAN PELT | — |
Copyright/Patent/Trademark CPT
Apportionment of damages and post-grant review of patents (S. 515; H.R. 1260)
| Lobbyist | Covered position, as disclosed |
|---|---|
| LAURIE MICHEL | — |
Budget/Appropriations BUD
Increased funding for CDC's National Immunization Program (Sec. 317 Program); increased funding for the AIDS Drug Assistance Program (FY 11 Budget and Labor-Health & Human Services Appropriations bill)
| Lobbyist | Covered position, as disclosed |
|---|---|
| LAURIE MICHEL | — |
Health Issues HCR
RX drug importation into the US, other than by drug's manufacturer (no specific bill). Requiring safety and cost savings certification by HHS Sec'y in any Rx drug importation legislation (no specific bill). Promote public/private partnerships for comparative effectiveness assessment (S. 1213). Physician Payments Sunshine Act of 2009 (S. 301). Health care reform; increasing coverage of uninsured; coverage of preventative services, including immunizations; expansion of the 340B pricing program to include additional covered entities and inpatient prescription drug utilization; maintaining market-based, private sector health care delivery system. (H.R. 3200; S. 1679; S. 1796; H.R. 3590; H.R. 4872)
| Lobbyist | Covered position, as disclosed |
|---|---|
| G LAWRENCE ATKINS | — |
| VICTORIA BLATTER | — |
| ERIN DARLING | — |
| ANNE ESPOSITO | — |
| JANE HORVATH | — |
| ELI JOSEPH | Leg. Ass't. White House Office of Leg Affs. |
| LAURIE MICHEL | — |
| ANGELA M STEWART | Leg. Counsel, Leg. Asst., Sen. John Warner |
| JASON BENJAMIN VAN PELT | — |
Medicare/Medicaid MMM
Efforts to amend the Medicare Modernization Act to impose government price controls on prescription drugs (no specific legislation). Efforts to ensure appropriate access to vaccines under Medicare (H.R. 3200; S. 1796; H.R. 3590). Expansion of or increase in Medicaid rebate (H.R. 3200; S. 1796;H.R. 3590; H.R. 4872).
| Lobbyist | Covered position, as disclosed |
|---|---|
| VICTORIA BLATTER | — |
| ERIN DARLING | — |
| ANNE ESPOSITO | — |
| JANE HORVATH | — |
| ELI JOSEPH | Leg. Asst. White House Off. of Leg. Affs. |
| LAURIE MICHEL | — |
| JASON BENJAMIN VAN PELT | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.